Investors in Ev

Sanaga Ventures focuses on investing in and nurturing new and emerging ventures across Sub-Saharan Africa. The firm is dedicated to building the capacity of its partners, enabling them to attain financial sustainability and operational scale. Sanaga Ventures' approach centers on identifying high-potential entrepreneurs and integrating them into its extensive network. Through close collaboration, they aim to develop compelling investment opportunities that appeal to the broader investment community.

Value Creation Capital (VCC) is a prominent venture capital firm based in the Netherlands, specializing in technology-driven investments across Europe. With a strategic focus on sectors like enterprise software, IT infrastructure, cybersecurity, and digital health, VCC targets early-stage and growth-stage companies poised for substantial growth and market disruption. The firm distinguishes itself by not only providing financial capital but also offering hands-on strategic support and industry expertise to its portfolio companies. This approach is designed to accelerate their growth trajectory, expand market presence, and strengthen operational capabilities. VCC's commitment to creating long-term value through proactive investment management and fostering synergistic partnerships underscores its role as a key player in nurturing innovation and driving sustainable business development within the technology sector. For entrepreneurs and companies seeking to scale their ventures with strategic backing, VCC serves as a trusted partner known for its collaborative approach and dedication to maximizing the potential of innovative businesses.

Oxford Science Enterprises is a venture firm partnered with universities, specializing in early-stage investments across life sciences, AI & software, and deep technology sectors. The firm leverages its close ties with academia to identify and support innovative startups with transformative potential. Oxford Science Enterprises provides strategic capital and operational expertise to help these ventures navigate their early growth phases and achieve market leadership. By focusing on cutting-edge technologies and scientific advancements, the firm aims to drive significant innovation and impact in global markets.

Takara Capital est actif en Venture Capital early-stage, soutenu par les grands entrepreneurs de la FrenchTech. Pionniers de la construction des incubateurs en France, nous bénéficions, avec 300+ entrepreneurs accompagnés, d'un sourcing unique au sein de l'écosystème. Nous investissons dans les entreprises au moment où elles en ont le plus besoin. Ce positionnement en Pré-Série A offre un rapport risque-valorisation-liquidité optimal. Nous privilégions les solutions technologiques B2B essentielles à l'économie digitale, disposant d'une preuve de marché monétisée, d'un modèle d'affaires scalable et d'un potentiel de croissance exceptionnel.

Our focus is on early-stage venture capital investments primarily in Quantum technology, FinTech innovations, and Data-driven startups across North America and Europe. We specialize in identifying and nurturing promising ventures at the cutting edge of technological advancement. By strategically investing in these sectors, we aim to support disruptive innovations that have the potential to reshape industries and drive sustainable growth. Our approach combines financial backing with active mentorship and access to a robust network of industry experts.

We believe traditional hurdles to innovation are being destroyed, empowering startups to innovate at unprecedented speed and scale. Combining deep market knowledge and sector expertise with a passion for building groundbreaking companies, we work alongside businesses to tackle the challenges of the global food economy. Our team operates out of Amsterdam, Boston, and London, maintaining a global outlook and fostering a diverse and inclusive approach to investment. Backed by leading limited partners (LPs), we aim to catalyze transformation with a world-class network, financial flexibility, and patient capital.

TRGC is committed to a hands-on approach with its portfolio companies, aiming to add value from day one. With over 15 years of industry experience, TRGC leverages its expertise to support promising founders who demonstrate visionary ideas and strong execution capabilities. The firm prioritizes active involvement and strategic guidance, working closely with entrepreneurs to navigate challenges, accelerate growth, and achieve impactful outcomes. TRGC's dedication to backing innovative ventures reflects its commitment to fostering long-term success and driving positive change within the industries it invests in. For more information, you can visit their website: TRGC

Based in Amsterdam, our entrepreneurial investment firm focuses exclusively on early-stage ventures within the online and mobile sectors. We are driven by a mission to identify and invest in passionate entrepreneurs who offer unique products or services with scalable potential and a recurring revenue model. Central to our investment strategy is our hatch philosophy, which emphasizes three key pillars: first, we bring clarity and focus to business planning, strategy development, and roadmap execution; second, we accelerate growth by leveraging our extensive network and industry connections to facilitate strategic partnerships and market access; and third, we catalyze the development of each venture's internal capabilities, fostering sustainable competitive advantages. Through strategic deployment of capital, hands-on mentorship, and access to our robust network, we empower entrepreneurs to realize their vision and establish leadership in the dynamic landscape of digital innovation.

BFly Ventures (formerly known as WoodWing Ventures), based in Zaandam, the Netherlands, is an early-stage venture capital company. We invest in ambitious, early-stage software companies with creative entrepreneurs, bright ideas, and promising products. Our focus is on nurturing innovation and supporting the growth of businesses that have the potential to disrupt markets and drive technological advancements. By providing both capital and strategic guidance, we help these companies navigate their early stages and accelerate their development. Our commitment is to fostering long-term success and creating value for both the entrepreneurs and our investors.

Anterra Capital is a global venture capital firm specializing in investments within the food and agricultural technology sectors. Founded in 2013 and headquartered in Amsterdam with an additional presence in San Francisco, Anterra focuses on backing innovative companies that tackle critical challenges in agriculture, food production, and sustainability. They invest across various stages, from early to growth-stage companies, supporting advancements in precision agriculture, biological inputs, alternative proteins, food safety, and supply chain optimization. Beyond capital, Anterra Capital provides strategic guidance and operational support, leveraging their international network to foster growth and impact.

First Degree Capital specializes in investing in pioneering AI and innovative B2B solutions that are reshaping the future of work. With a strategic focus on cutting-edge technologies, First Degree Capital identifies and supports startups at the forefront of industry transformation. By providing crucial capital and strategic resources, they empower visionary entrepreneurs to scale their businesses and drive meaningful impact in the workplace ecosystem. Focused on the convergence of AI and B2B innovation, First Degree Capital plays a pivotal role in accelerating the adoption of disruptive technologies that enhance productivity, efficiency, and competitiveness across various sectors. Their investment philosophy centers on fostering innovation and supporting companies poised to redefine how businesses operate in the digital age. Through active partnership and dedicated support, First Degree Capital contributes to advancing the frontier of work, ensuring that their portfolio companies lead in creating solutions that meet the evolving demands of the global market.

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses. Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies. By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market. Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally.